Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Alzheimer's & Dementia

• Publication date

  2013-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jalz.2012.12.001PMID 23562430PMCID PMC3766403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Neuropsychiatric symptoms in Alzheimer's disease

  2011influential reference
• Neuropsychiatric Predictors of Progression from Amnestic-Mild Cognitive Impairment to Alzheimer's Disease: The Role of Depression and Apathy

  2010cited by this paper
• Genetics of Psychosis in Alzheimer's Disease: A Review

  2010cited by this paper
• Targeting and Managing Behavioral Symptoms in Individuals with Dementia: A Randomized Trial of a Nonpharmacological Intervention

  2010cited by this paper
• The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia

  2010influential reference
• Organising the language of Alzheimer's disease in light of biomarkers.

  2010cited by this paper
• Revising the definition of Alzheimer's disease: a new lexicon.

  2010cited by this paper
• Serotonin modulation of cerebral glucose metabolism in depressed older adults.

  2009cited by this paper
• Double-blind treatment of apathy in patients with poststroke depression using nefiracetam.

  2009cited by this paper
• Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.

  2009cited by this paper
• Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease

  2009cited by this paper
• Scales as outcome measures for Alzheimer's disease

  2009cited by this paper
• Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study.

  2008influential reference
• Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6‐week, double‐blind, placebo‐controlled study

  2008cited by this paper
• Imaging Alzheimer Pathology in Late-Life Depression With PET and Pittsburgh Compound-B

  2008cited by this paper
• Translational Research in Late-Life Mood Disorders: Implications for Future Intervention and Prevention Research

  2007cited by this paper
• Positron emission tomography metabolic correlates of apathy in Alzheimer disease.

  2007cited by this paper
• Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.

  2006cited by this paper
• Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

  2006cited by this paper
• The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers

  2006cited by this paper
• Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review.

  2006cited by this paper
• The vascular depression hypothesis: 10 years later.

  2006cited by this paper
• Mild Cognitive Impairment is Associated With Characteristic Neuropsychiatric Symptoms

  2004cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial.

  2003cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease.

  2003cited by this paper
• The integration of neurology, psychiatry, and neuroscience in the 21st century.

  2002cited by this paper
• Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  2002cited by this paper
• Principles of Behavioral and Cognitive Neurology, 2nd Ed.

  2002cited by this paper
• Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

  2002cited by this paper
• The 5-HTTPR Polymorphism Confers Liability to a Combined Phenotype of Psychotic and Aggressive Behavior in Alzheimer Disease

  2001cited by this paper
• [Vascular depression].

  2001cited by this paper
• A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease.

  2001cited by this paper
• Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study

  2001cited by this paper
• Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.

  2000influential reference
• Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

  2000cited by this paper
• Neurology and psychiatry

  2000cited by this paper
• A 5-month, randomized, placebo-controlled trial of galantamine in AD

  2000cited by this paper
• Neurology and psychiatry: closing the great divide.

  2000cited by this paper
• Principles of Behavioral and Cognitive Neurology

  2000cited by this paper
• A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

  1999cited by this paper
• Frontal-subcortical circuits and human behavior.

  1998cited by this paper
• A human cerebral deconnection syndrome: a preliminary report. 1962.

  1998cited by this paper
• From sensation to cognition.

  1998cited by this paper
• 'Vascular depression' hypothesis.

  1997cited by this paper
• Cornell Scale for Depression in Dementia

  1997cited by this paper
• Impact of Sample Selection on APOE ∈4 Allele Frequency: A Comparison of Two Alzheimer's Disease Samples

  1996cited by this paper
• Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease.

  1996cited by this paper
• Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer's disease samples.

  1996cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• Longitudinal, Expert, All Data Procedure for Psychiatric Diagnosis in Patients with Psychoactive Substance Use Disorders

  1994cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1993influential reference
• Frontal-subcortical circuits and human behavior.

  1993cited by this paper
• J Neuropsychiatry Clin Neurosci

  1992cited by this paper
• Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist.

  1992cited by this paper
• Apathy: a neuropsychiatric syndrome.

  1991cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991influential reference
• Clinical diagnosis of Alzheimer's disease

  1991cited by this paper
• Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.

  1991cited by this paper
• Neurochemical correlates of major depression in primary dementia.

  1990cited by this paper
• Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

  1990cited by this paper
• Large‐scale neurocognitive networks and distributed processing for attention, language, and memory

  1990cited by this paper
• An Observational Study of Agitation in Agitated Nursing Home Residents

  1989cited by this paper
• Overview of depression and psychosis in Alzheimer's disease.

  1989cited by this paper
• Cornell Scale for Depression in Dementia.

  1988cited by this paper
• Standardization and validation of the Multidimensional Observation Scale for Elderly Subjects (MOSES).

  1987cited by this paper
• Alzheimer’s Dementia

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Psychogeriatric Dependency Rating Scales (PGDRS) A Method of Assessment for Use by Nurses

  1980cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper
• Uber eine eigenartige Erkrankung der Hirnrinde

  year unknowncited by this paper

• Silk fibroin@polydopamine for acupoint catgut-embedding therapy in Alzheimer's disease.

  2026cites this paper
• Mental health symptoms as preclinical indicators of dementia: a Whitehall II cohort study

  2026cites this paper
• Long-term effects of forty-hertz auditory stimulation as a treatment of Alzheimer’s disease: Insights from an aged monkey model study

  2026cites this paper
• Executive and General Cognitive Domain as a Relevant Factor of Specific Neuropsychiatric Symptoms in Alzheimer's Disease

  2026influential citation
• Neuropsychiatric symptoms in Alzheimer's disease: Past, present, and future

  2026cites this paper
• Multiplex Cerebrospinal Fluid Proteomics Identifies Biomarkers Predicting Neuropsychiatric Symptom Progression in Mild Cognitive Impairment and Alzheimer's Disease

  2026cites this paper
• Structural Brain Correlates With Appetite and Eating Disturbances Across the Alzheimer Disease Spectrum.

  2026cites this paper
• Depression and Cognitive Outcomes: Linking the Mayo Clinic Study of Aging and Rochester Epidemiology Project.

  2025cites this paper
• Uncovering the Role of Neuropsychiatric Symptoms in Cognitive Impairment Progression

  2025cites this paper
• Heterogeneous treatment effects of BCG vaccine on Alzheimer's disease risk

  2025cites this paper
• Structural Neuroimaging Correlates of Neuropsychiatric Symptoms in Alzheimer’s Disease: A Systematic Literature Review

  2025cites this paper
• Specific cognitive impairment predicts the neuropsychiatric symptoms in patient with mild cognitive impairment

  2025cites this paper
• Insulin-like Growth Factor 1 Impact on Alzheimer’s Disease: Role in Inflammation, Stress, and Cognition

  2025cites this paper
• Mapping the Neuropsychiatric Symptoms in Alzheimer’s Disease Using Biomarkers, Cognitive Abilities, and Personality Traits: A Systematic Review

  2025influential citation
• Stratifying dementia risk factors: A prediction model and hypothesis‐driven analysis

  2025cites this paper
• Effects of Cognitive Interventions on Activities of Daily Living and Behavioral and Psychological Symptoms in Neurocognitive Disorder

  2025cites this paper
• Plasma biomarkers in neuropsychiatric syndromes: A narrative review

  2025cites this paper
• Neuropsychiatric symptoms and neuroimaging‐based brain age in mild cognitive impairment and early dementia: A multicenter study

  2025cites this paper
• Nociceptin receptor and ligand in Alzheimer’s disease: Implications for psychiatric symptoms and circadian regulation

  2025cites this paper
• Cognitive and Non-Cognitive Predictors of Response to Cognitive Stimulation Interventions in Dementia: A Systematic Review Aiming for Personalization

  2025cites this paper
• Longitudinal associations between amyloid and symptoms of depression and anxiety in subjective cognitive decline: the impact of personality characteristics

  2025cites this paper
• Empirical classification of neuropsychiatric symptoms and association of classes with diagnostic progression and cognitive decline in MCI and AD populations.

  2025cites this paper
• Apathy in Alzheimer's disease: Eye movements characteristics and neurostructural basis.

  2025cites this paper
• When aggression (re)structures the relationship bonds between caregiver and care receiver in neurodegenerative diseases: A systematic review

  2025cites this paper
• Preliminary evidence for preserved synaptic density in late-life depression

  2024cites this paper
• Exploring the Genetic Landscape of Mild Behavioral Impairment as an Early Marker of Cognitive Decline: An Updated Review Focusing on Alzheimer’s Disease

  2024cites this paper
• Distinguishing features of depression in dementia from primary psychiatric disease

  2024cites this paper
• Neuropsychiatric and Cognitive Symptoms: Two Sides of the Same Coin?

  2024cites this paper
• Knowledge Structure and Emerging Trends of Mild Cognitive Impairment with Dyssomnias in Recent 20 Years: A Bibliometric Analysis via CiteSpace and VOSviewer

  2024cites this paper
• Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment

  2024cites this paper
• Personality traits and measures of neuropsychiatric symptoms

  2024cites this paper
• Extracts of Sideritis scardica and Clinopodium vulgare Alleviate Cognitive Impairments in Scopolamine-Induced Rat Dementia

  2024cites this paper
• Neuropsychiatric symptom burden in early‐onset and late‐onset Alzheimer's disease as a function of age

  2024cites this paper
• Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia

  2024cites this paper
• Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer’s Disease: A Data-Driven Meta-Analysis with N = 3,118

  2024cites this paper
• Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias.

  2024cites this paper
• Therapeutic potential of clinically proven natural products in the management of dementia

  2024cites this paper
• Subsyndromes and symptom clusters: Multilevel factor analysis of behavioral and psychological symptoms of dementia with intensive longitudinal data

  2024cites this paper
• The neural basis of neuropsychiatric symptoms in Alzheimer’s disease

  2024cites this paper
• Aripiprazole mitigates lipopolysaccharide-induced memory impairments in rats

  2024cites this paper
• Prevalence of Psychotic Symptoms in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.

  2024cites this paper
• Increase in blood pressure precedes distress behavior in nursing home residents with dementia.

  2024cites this paper
• Assessing the Stability of Clusters of Neuropsychiatric Symptoms in Alzheimer's Disease and Mild Cognitive Impairment.

  2024cites this paper
• Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier

  2024cites this paper
• Resveratrol-Loaded Pluronic Micelles Ameliorate Scopolamine-Induced Cognitive Dysfunction Targeting Acetylcholinesterase Activity and Programmed Cell Death

  2024cites this paper
• Mild behavioral impairment in early Alzheimer’s disease and its association with APOE and BDNF risk genetic polymorphisms

  2024cites this paper
• Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline

  2023cites this paper
• Lower cognitive function attenuates the convergence between self‐ratings and observer ratings of depressive symptoms in late‐life cognitive impairment

  2023cites this paper
• Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice

  2023cites this paper
• Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer’s Disease: A Literature Review from a Machine Learning Perspective

  2023cites this paper
• Generation and Characterization of a Human-Derived and Induced Pluripotent Stem Cell (iPSC) Line from an Alzheimer’s Disease Patient with Neuropsychiatric Symptoms

  2023cites this paper
• Alleviation of behavioral deficits, amyloid-β deposition, and mitochondrial structure damage associated with mitophagy upregulation in AD animal models via AAV9-IGF-1 treatment.

  2023cites this paper
• Characterization of apathy-like behaviors in the 5xFAD mouse model of Alzheimer's disease.

  2023cites this paper
• Nourishing the Cognition with Millets: A Comprehensive Review of Their Nutritional Impact and Potential as Cognitive Enhancers.

  2023cites this paper
• Oligonol ameliorates liver function and brain function in the 5 × FAD mouse model: transcriptional and cellular analysis.

  2023cites this paper
• Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment

  2023cites this paper
• Non-Genetic Risk Factors for Dementia and Alzheimer’s Disease

  2023cites this paper
• Common Neuropsychiatric Symptoms in Alzheimer's Disease, Mild Cognitive Impairment, and Subjective Memory Complaints: A Unified Framework.

  2023cites this paper
• Apathy-like behaviour in tau mouse models of Alzheimer's disease and frontotemporal dementia.

  2023cites this paper
• Neuropsychiatric Symptoms and In Vivo Alzheimer’s Biomarkers in Mild Cognitive Impairment

  2023cites this paper
• Psychiatric Disorders Before and After Dementia Diagnosis

  2023cites this paper
• Neuropsychiatric Symptoms of Alzheimer’s Disease: An Anatomic-Genetic Framework for Treatment Development

  2023cites this paper
• Uric acid index is a risk for mild cognitive impairment in type 2 diabetes

  2023cites this paper
• Docking of Alkaloid as a Source of Potential Anticholinesterase Inhibitors for the Treatment of Alzheimer’s Disease

  2023cites this paper
• Plasma‐derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community‐based study

  2023cites this paper
• Association of Early-, Middle-, and Late-Life Depression With Incident Dementia in a Danish Cohort.

  2023cites this paper
• Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer’s Disease

  2023cites this paper
• The reporting of neuropsychiatric symptoms in electronic health records of individuals with Alzheimer’s disease: a natural language processing study

  2023cites this paper
• Sex Differences in Alzheimer's Disease.

  2023cites this paper
• Context is not key: Detecting Alzheimer's disease with both classical and transformer-based neural language models

  2023cites this paper
• A 2023 update on the advancements in the treatment of agitation in Alzheimer’s disease

  2023influential citation
• Association Between False Memories and Delusions in Alzheimer Disease.

  2023cites this paper
• The effect of music therapy on cognitive functions in patients with Alzheimer’s disease: a systematic review of randomized controlled trials

  2023cites this paper
• Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study

  2023cites this paper
• Disrupted topological organization of functional brain networks in Alzheimer’s disease patients with depressive symptoms

  2022cites this paper
• Effect of online tDCS to left somatomotor cortex on neuropsychiatric symptoms among older adults at risk for dementia.

  2022cites this paper
• Discourse and conversation impairments in patients with dementia

  2022cites this paper
• Phyto-Therapeutic and Nanomedicinal Approaches: A New Hope for Management of Alzheimer's Disease.

  2022cites this paper
• Naturally occurring Alzheimer’s disease in rhesus monkeys

  2022cites this paper
• Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases.

  2022cites this paper
• The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer’s Disease

  2022cites this paper
• Visit-To-Visit Blood Pressure Variability and Subthreshold Depressive Symptoms in Older Adults.

  2022cites this paper
• Understanding How Physical Exercise Improves Alzheimer’s Disease: Cholinergic and Monoaminergic Systems

  2022cites this paper
• Empirical and Authoritative Classification of Neuropsychiatric Syndromes in Neurocognitive Disorders.

  2022cites this paper
• Quantifying the qualitative: exploring epistemic network analysis as a method to study work system interactions

  2022cites this paper
• Exploring how caregivers for people living with dementia use strategies to overcome work system constraints.

  2022cites this paper
• Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging

  2022cites this paper
• Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship?

  2022cites this paper
• Behavioural and Psychological Symptoms of Dementia – Assessment and Management

  2022cites this paper
• Neuropsychiatric Inventory–Questionnaire Assessed Nighttime Behaviors in Cognitively Asymptomatic Patients with Pathologically Confirmed Alzheimer’s Disease Predict More Rapid Cognitive Deterioration

  2022cites this paper
• Management of neuropsychiatric symptoms in dementia

  2022cites this paper
• Psychosis in Alzheimer disease — mechanisms, genetics and therapeutic opportunities

  2022cites this paper
• Could Towel bath reduce aggressiveness in patient with dementia? Results from a crossover trial

  2022cites this paper
• Relations of neuropsychiatric symptoms with disease stage, sex, and daily function in mild cognitive impairment and dementia due to Alzheimer's disease: A cross-sectional study.

  2022cites this paper
• Neuropsychiatric Inventory domains cluster into neuropsychiatric syndromes in Alzheimer's disease: A systematic review and meta‐analysis

  2022cites this paper
• Quetiapine Abuse in Illicit Drug Users or Sellers: To Screen or Not to Screen?

  2021cites this paper
• Adjunctive Therapy to Manage Neuropsychiatric Symptoms in Moderate and Severe Dementia: Randomized Clinical Trial Using an Outpatient Version of Tailored Activity Program

  2021cites this paper
• Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer’s disease with dementia

  2021cites this paper
• Quantitative Assessment of Cortical Excitability in Alzheimer’s Dementia and Its Association with Clinical Symptoms: A Systematic Review and Meta-Analyses

  2021cites this paper
• Lack of physical activity, neuropsychiatric symptoms and the risk of incident mild cognitive impairment in older community-dwelling individuals

  2021cites this paper